Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance.
about
Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.Imaging of multiple sclerosis: role in neurotherapeutics.MRI in multiple sclerosis: what's inside the toolbox?MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain.Differential cognitive impairment for diverse forms of multiple sclerosis.The MT pool size ratio and the DTI radial diffusivity may reflect the myelination in shiverer and control mice.Multiple sclerosis lesions: insights from imaging techniques.Diffusion imaging in multiple sclerosis: research and clinical implications.Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted imagesQuantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosisMagnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability.Simulations on the influence of myelin water in diffusion-weighted imaging.DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.How changes in brain activity and connectivity are associated with motor performance in people with MS.Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study.White matter mapping using diffusion tensor MRI.Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.A novel fast split-echo multi-shot diffusion-weighted MRI method using navigator echoes.Sequential diffusion-weighted magnetic resonance imaging study of lysophosphatidyl choline-induced experimental demyelinating lesion: an animal model of multiple sclerosis.Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: a case report.Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction.Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.Lipid biochemical changes detected in normal appearing white matter of chronic multiple sclerosis by spectral coherent Raman imaging.Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matterT1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis
P2860
Q30585635-FF566081-6408-4444-A19B-725B9C4538ECQ30989935-C0D40800-1156-4C2E-9C21-967C9709DA89Q31132442-79E85E5B-7F54-4619-ADCF-6821B334221FQ33211281-53060A31-7FD0-473A-A80C-1525FFF72854Q33244102-EC492E5D-93D9-4030-9F82-C8E8EB5334B5Q33397430-89ED8917-1507-4C52-86C4-4760BF3FFFA6Q33505423-0F63FC17-6CAB-4C03-ABF2-D2B35DB5861EQ33706390-20380143-8848-48CE-8998-15A693EF42ABQ35454159-4A87B08B-F4BE-4E1F-B8A6-9353D740FADFQ35460988-1B9AA536-9FAE-4FE2-84EE-D985674E2280Q35461315-6CE8B799-618D-4CC8-8E50-6C7E3769007EQ35471633-1B2C4196-F31C-4D5D-8F5C-83F5B96B83ACQ37055772-F178101B-6107-4596-8E9A-5BC5A3CE8E8EQ39902923-F5C2AB77-8E6D-46B8-BC9F-0A29523F8641Q42454590-349DD25F-4FE3-4C24-B16D-9C6E8601F805Q42654793-30DE6954-39E3-4A14-8A7D-2C028DF23711Q43239622-4DF4BC85-3F0D-4E52-ABAC-D3BD0C9C8941Q43973297-18C03170-052B-4B7C-8BAA-FAB41D4F1BE9Q46054853-3474B9C3-DA47-427F-8D95-D7DC85EBCCCAQ47939953-4CDEFBFB-AB7F-4F8A-A97D-940C5053D509Q48206959-9843A031-568E-4345-9DD6-DE8228D00266Q48496900-275D81D6-EF08-4FE4-81AC-D96767D93796Q48597616-A5F3E9AF-B742-4679-9C19-4D0C2754511FQ48695743-047FF557-BE81-4FFA-9CC3-2D72AB63BB3AQ52003876-5C29E1BE-B5B2-4E1A-97E2-ED13BAE89500Q52097042-2B03A119-8DB0-45B5-8734-718FE4AAFED6Q55002027-6A915586-9A89-4FF3-A103-D73859E0F649Q57274242-F896360B-A62D-4AC0-BE66-9C05D49ADEA4Q57911932-FABDFEDA-4F97-480B-801F-C0E368929612
P2860
Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Apparent diffusion coefficient ...... by nuclear magnetic resonance.
@en
type
label
Apparent diffusion coefficient ...... by nuclear magnetic resonance.
@en
prefLabel
Apparent diffusion coefficient ...... by nuclear magnetic resonance.
@en
P2093
P2860
P356
P1476
Apparent diffusion coefficient ...... by nuclear magnetic resonance.
@en
P2093
D H Miller
G J Barker
M A Horsfield
P2860
P304
P356
10.1002/MRM.1910360310
P577
1996-09-01T00:00:00Z